CRP and breast cancer: While both elevated serum CRP and SAA were associated with an increased risk of breast cancer relapse, the biologic (additive) interaction analysis between these two biomarkers does not suggest a synergistic effect in which elevated levels of both biomarkers drastically increases one’s risk of relapse.